Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B. (Q44516044)

3 December 2017

Measurement of plasma small-dense LDL concentration by a simplified ultracentrifugation procedure and immunoassay of apolipoprotein B. (English)

1 reference

3 December 2017

Valentine C Menys

1

1 reference

3 December 2017

Yifen Liu

2

1 reference

3 December 2017

Michael I Mackness

3

1 reference

3 December 2017

Muriel J Caslake

4

1 reference

3 December 2017

See Kwok

5

1 reference

3 December 2017

Paul N Durrington

6

1 reference

3 December 2017

1 August 2003

1 reference

3 December 2017

1 reference

3 December 2017

334

1 reference

3 December 2017

1-2

1 reference

3 December 2017

95-106

1 reference

Cardiovascular disease risk profiles.

3 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Sick individuals and sick populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Composition and distribution of low density lipoprotein fractions in hyperapobetalipoproteinemia, normolipidemia, and familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Québec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Remarkably high prevalence of small dense low-density lipoprotein in Japanese men with coronary artery disease, irrespective of the presence of diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Understanding coronary heart disease as a consequence of defective regulation of apolipoprotein B metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Lipoprotein subclasses and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

High apolipoprotein B with low high-density lipoprotein cholesterol and normal plasma triglycerides and cholesterol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Rapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

LDL particle size distribution is associated with carotid intima-media thickness in healthy 50-year-old men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Genetic factors associated with response of LDL subfractions to change in the nature of dietary fat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Lipoprotein(a) and coronary heart disease. Meta-analysis of prospective studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Determinants of LDL subfraction distribution and concentrations in young normolipidemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Ratio of triglycerides to HDL cholesterol is an indicator of LDL particle size in patients with type 2 diabetes and normal HDL cholesterol levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Regulation of small dense LDL concentration in Korean and Scottish men and women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Clinical evaluation of plasma high-density lipoprotein subfractions (HDL2, HDL3) in non-insulin-dependent diabetics with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

Effects of linoleate-enriched and oleate-enriched diets in combination with alpha-tocopherol on the susceptibility of LDL and LDL subfractions to oxidative modification in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Change in LDL particle size is associated with change in plasma triglyceride concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2803%2900231-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0009-8981(03)00231-6

1 reference

3 December 2017

1 reference